ArticlePharmaceuticals (Basel, Switzerland)2025
Design and Characterization of Thermosensitive Niosomes as Platforms for Daunorubicin Delivery.
Viliana Gugleva, Katerina Ahchiyska, Elena Drakalska-Sersemova, Rositsa Mihaylova, Natalia Toncheva-Moncheva, Erik Dimitrov, Krum Aleksandrov, Aleksander Forys, Barbara Trzebicka, Denitsa Momekova
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Viliana GuglevaDepartment of Pharmaceutical Technologies, Faculty of Pharmacy, Medical University of Varna, 84 Tsar Osvoboditel Str., 9000 Varna, Bulgaria.ORCID 0000-0002-6681-8150 Katerina AhchiyskaDepartment of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria.
Elena Drakalska-SersemovaFaculty of Medical Sciences, Goce Delcev University, 2000 Stip, North Macedonia.ORCID 0009-0005-0322-0935 Rositsa MihaylovaDepartment of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria.ORCID 0000-0001-5763-0730 Natalia Toncheva-MonchevaInstitute of Polymers, Bulgarian Academy of Sciences, bl.103 Akad. G. Bonchev Str., 1113 Sofia, Bulgaria.ORCID 0000-0002-7257-1107 Erik DimitrovInstitute of Polymers, Bulgarian Academy of Sciences, bl.103 Akad. G. Bonchev Str., 1113 Sofia, Bulgaria.
Krum AleksandrovInstitute of Polymers, Bulgarian Academy of Sciences, bl.103 Akad. G. Bonchev Str., 1113 Sofia, Bulgaria.
Aleksander ForysCentre of Polymer and Carbon Materials, Polish Academy of Sciences, ul. M. Curie-Skłodowskiej 34, 41-819 Zabrze, Poland.ORCID 0000-0002-6994-868X Barbara TrzebickaCentre of Polymer and Carbon Materials, Polish Academy of Sciences, ul. M. Curie-Skłodowskiej 34, 41-819 Zabrze, Poland.ORCID 0000-0002-6131-4017 Denitsa MomekovaDepartment of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria.ORCID 0000-0001-8112-6761 Funding
European Union's Next Generation EU economic recovery package via the National Recovery and Resilience Plan of the Republic of Bulgaria BGRRP-2.004-0004-C01
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
antiproliferative activitycancercarboxyfluoresceindaunorubicin hydrochlorideniosomesthermosensitivity
Identifiers
PMID41011243
PMCPMC12472712
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390